AUCrefTmax [Regulatives / Guidelines]

posted by raghup – India, 2021-05-28 12:44 (62 d 14:54 ago) – Posting: # 22376
Views: 493

For an NSAID immediate release Soft gelatin capsules with two way crossover study although if AUCt and Cmax are with in acceptance limits and there is no difference in median Tmax of both Test and Reference, but for AUCrefTmax 90% CI is not within 80-125% (will Health Canada accept the BE study). No outliers detected in the study.

Edit: Please follow the Forum’s Policy[Helmut]

Complete thread:

 Admin contact
21,592 posts in 4,514 threads, 1,532 registered users;
online 16 (0 registered, 16 guests [including 5 identified bots]).
Forum time: Friday 03:39 CEST (Europe/Vienna)

It is a capital mistake to theorise before one has data.    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz